0 items USD 0.00Search
Your search for "Mantle cell lymphoma" gave back 8616 results.
The global Rituxan (Rituximab) and Biosimilar market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is projected to grow from US$ 4035.3 million in 2022 to US$ 5179.6 million in 2029; it...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Chimeric Antigen Receptor Cell Therapy Market The global Chimeric Antigen Receptor Cell Therapy market is...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Radioimmunotherapy market size was valued at USD 1073 million in 2022 and is forecast to a readjusted size of USD 3159.2 million by 2029...
Catalog:
GIR
September 2023
Price: USD 3,480.00
The global Hadron Therapy market was valued at US$ 1500 million in 2023 and is anticipated to reach US$ 2604.2 million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Rituxan (Rituximab) and Biosimilar market size is expected to reach $ 5345.4 million by 2029, rising at a market growth of 3.3% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Rituxan (Rituximab) Monoclonal Antibody market size is expected to reach $ 5345.4 million by 2029, rising at a market growth of 3.3% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
BTK inhibitors are able to interfere with cell signaling cascades and prevent key phosphorylations in B cells, therefore preventing or reducing...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Tissue Diagnostics Instrument market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Check point inhibitors are molecules that use the cosmic potential of the immune response system of the body, and its limitless influences to attack...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Anti-CD25 Monoclonal Antibody market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
December 2023
Price: USD 4,480.00
Therapeutic Radioligands is a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the destructive power of...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
